BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35993578)

  • 21. Clear cell tumor with melanocytic differentiation and MITF::CREM translocation.
    Alexandrescu S; Imamovic-Tuco A; Janeway K; Hanna J
    J Cutan Pathol; 2023 Jul; 50(7):619-622. PubMed ID: 37057373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma.
    Deyrup AT; Althof P; Zhou M; Morgan M; Solomon AR; Bridge JA; Weiss SW
    Am J Surg Pathol; 2004 Dec; 28(12):1579-86. PubMed ID: 15577676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities.
    Graadt van Roggen JF; Mooi WJ; Hogendoorn PC
    J Pathol; 1998 Sep; 186(1):3-7. PubMed ID: 9875133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
    Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
    Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic comparison between clear cell sarcoma and a case of acral clear cell melanoma.
    Zelger BG; Debiec-Rychter M; Sciot R; Zelger B
    J Dtsch Dermatol Ges; 2003 May; 1(5):363-8. PubMed ID: 16285301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma.
    de la Fouchardiere A; Pissaloux D; Tirode F; Hanna J
    Virchows Arch; 2021 Oct; 479(4):841-846. PubMed ID: 33462743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.
    Ko JS; Lemahieu J; Billings SD; Tirode F; Payton D; Boone B; Pissaloux D; de la Fouchardiere A
    Mod Pathol; 2024 Apr; 37(4):100438. PubMed ID: 38278485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
    Tran TAN; Linos K; de Abreu FB; Carlson JA
    Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRAME Expression in Challenging Dermal Melanocytic Neoplasms and Soft Tissue Tumors With Melanocytic Differentiation.
    Kline N; Menge TD; Hrycaj SM; Andea AA; Patel RM; Harms PW; Chan MP; Bresler SC
    Am J Dermatopathol; 2022 Jun; 44(6):404-410. PubMed ID: 34991102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma.
    Garcia JJ; Kramer MJ; Mackey ZB; O'Donnell RJ; Horvai AE
    Arch Pathol Lab Med; 2006 Mar; 130(3):343-8. PubMed ID: 16519562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of primary dermal clear cell sarcoma with focal epidermotropism: An entity difficult to distinguish from melanoma.
    Nawrocki S; Fitzhugh VA; Groisberg R; Aviv HA; Maghari A
    J Cutan Pathol; 2020 Jul; 47(7):621-624. PubMed ID: 32012324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 35. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
    Tang J; Tian Z; Liao X; Wu G
    Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
    Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
    Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compound Clear Cell Sarcoma of the Skin-A Potential Diagnostic Pitfall: Report of a Series of 4 New Cases and a Review of the Literature.
    Luzar B; Billings SD; de la Fouchardiere A; Pissaloux D; Alberti L; Calonje E
    Am J Surg Pathol; 2020 Jan; 44(1):21-29. PubMed ID: 31688004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Clear Cell Sarcoma of the Dermis Mimicking Malignant Melanoma.
    Obiorah IE; Brenholz P; Özdemirli M
    Balkan Med J; 2018 Mar; 35(2):203-207. PubMed ID: 29072181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation.
    Aue G; Hedges LK; Schwartz HS; Bridge JA; Neff JR; Butler MG
    Cancer Genet Cytogenet; 1998 Aug; 105(1):24-8. PubMed ID: 9689926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Chen Y; Li L; Qian X; Ge Y; Xu G
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):190-196. PubMed ID: 28065743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.